Overview of COVID‐19 testing and implications for otolaryngologists
- 12 May 2020
- journal article
- research article
- Published by Wiley in Head & Neck
- Vol. 42 (7), 1629-1633
- https://doi.org/10.1002/hed.26213
Abstract
Background Testing for SARS‐CoV‐2 is important for decision making prior to surgery in otolaryngology. An understanding of current and developing testing methods is important for interpreting test results. Methods We performed a literature review of current evidence surrounding SARS‐CoV‐2 diagnostic testing highlighting its utility, limitations, and implications for otolaryngologists. Results The currently accepted RT‐PCR test for SARS‐CoV‐2 has varying sensitivity according to which subsite of the aerodigestive tract is sampled. Nasal swab sensitivities appear to be about 70%. Chest CT imaging for screening purposes is not currently recommended. Conclusion Due to the current sensitivity of RT‐PCR based testing for SARS‐CoV‐2, a negative test cannot rule out COVID‐19. Full PPE should be worn during high risk procedures such as aerosol generating procedures even if testing is negative. Patients who test positive during screening should have their surgeries postponed if possible until asymptomatic and have tested negative for SARS‐CoV‐2.Keywords
This publication has 26 references indexed in Scilit:
- Positive RT-PCR Test Results in Patients Recovered From COVID-19JAMA, 2020
- Presumed Asymptomatic Carrier Transmission of COVID-19JAMA, 2020
- SARS-CoV-2 Viral Load in Upper Respiratory Specimens of Infected PatientsThe New England Journal of Medicine, 2020
- Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus–Infected Pneumonia in Wuhan, ChinaJAMA, 2020
- Coronavirus Infections—More Than Just the Common ColdJAMA, 2020
- Public awareness, news promptness and the measles outbreak in Hong Kong from March to April, 2019Infectious Diseases, 2020
- Clinical features of patients infected with 2019 novel coronavirus in Wuhan, ChinaThe Lancet, 2020
- Wave-CAIPI susceptibility-weighted imaging achieves diagnostic performance comparable to conventional susceptibility-weighted imaging in half the scan timeEuropean Radiology, 2020
- CRISPR-Cas14 is now part of the artillery for gene editing and molecular diagnosticNanomedicine: Nanotechnology, Biology and Medicine, 2019